COPD Foundation to Host Patient-Focused Drug Development Meeting
The COPD Foundation announced an upcoming meeting to ensure patient experiences and priorities are incorporated into the future of therapeutic development.
The COPD Foundation announced an upcoming meeting to ensure patient experiences and priorities are incorporated into the future of therapeutic development.
The room-temperature-stable freeze-dried plasma product provides a new option for patients in remote or austere environments where conventional frozen plasma is unavailable.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
A standard laboratory assay significantly underestimates blood sugar levels in people with sickle cell trait, potentially leading to widespread underdiagnosis of diabetes.
The collaboration will focus on a point-of-care testing platform designed to detect tuberculosis from respiratory and blood samples.
Pressure control-volume guarantee (PCV-VG) ventilation improved intraoperative respiratory mechanics but did not significantly reduce postoperative pulmonary complications compared with conventional volume control ventilation in patients undergoing emergency abdominal surgery.
Three research teams are developing noninvasive, cost-effective screening tools to improve lung cancer detection rates among smokers and non-smokers.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.